Treatment.com AI Provides Corporate Update
Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to […]
BIGG Digital Assets Inc. Wholly Owned Subsidiary TerraZero Technologies Inc. and FINLITI Announce Strategic Partnership to Pioneer the Next Era of Financial Literacy & Investing with TerraZero’s ‘Intraverse’
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: […]
HeartCore Signs 12th Go IPO Contract
NEW YORK and TOKYO, Feb. 29, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
NETSOL’s Calculation Engine Flex Now Empowering Haydock Finance’s Broker Division
ENCINO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application […]
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from […]
Moblico Partners with Bridgeline’s HawkSearch to Introduce AI-driven Mobile Product Search for Distributors
WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced […]
VERB’S MARKET.live Second Frankie Avalon Livestream Shopping Show Draws More Than 25,000 Viewers
LOS ALAMITOS, Calif. and LAS VEGAS, Feb. 29, 2024 (GLOBE NEWSWIRE) — Get ready for another extraordinary livestream shopping experience […]
Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized […]
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5
Murine Study by the Wistar Institute Builds Upon Favorable Results Previously Reported by IMUNON With its Prototype PlaCCine Vaccine Modality […]
Actelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber Security
FREMONT, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in […]
